Prescient Therapeutics Ltd Cash Flow Reinvestment Rate
Prescient Therapeutics Ltd cash flow reinvestment rate. Prescient Therapeutics Ltd (PTX) has a Cash Flow Reinvestment Rate of 0.00x as of June 2013, reinvesting AU$0.00 (capex AU$0.00 ) from operating cash flow of AU$32.65K. Explore PTX operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Prescient Therapeutics Ltd (1991–1993)
Cash flow reinvestment rate of Prescient Therapeutics Ltd from 1991 to 1993. Historical reinvestment intensity for Prescient Therapeutics Ltd across 2 annual periods. Explore PTX capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Prescient Therapeutics Ltd Cash Flow Reinvestment Rate by Year (1991–1993)
Prescient Therapeutics Ltd cash flow reinvestment rate by year from 1991 to 1993. Year-by-year capital reinvestment analysis for Prescient Therapeutics Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Prescient Therapeutics Ltd.
| Year | Reinvestment Rate | Total Reinvested (AUD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 1993 | 0.32x | AU$562.00K | AU$1.74 Million | AU$562.00K | ▼ -12.3% |
| 1991 | 0.37x | AU$269.00K | AU$730.00K | AU$269.00K | — |